Monte Rosa Therapeutics GLUE Institutional Ownership

NASDAQ GLUE

$13.84 -0.54 (-3.76%)

As of: Sep 4, 2026 · 3:59 PM EDT

Institutions by Trading Activity

194 Institutions

Increased 111 57.2%

Unchanged 25 12.9%

Reduced 58 29.9%

Ownership Statistics

13F · as of 30 Jun, 2026

Institutional Ownership

91.93%

▲+4.19 pp QoQ

Shares Held by Institutions

93.29Mn

of 101.48Mn outstanding

▲+10.43% QoQ

Shares Outstanding

101.48Mn

8.19Mn held outside 13F filers

Institutional Investors

194

filed 13F for Jun 2026

▲+4 vs prior quarter

Net Shares Added (QoQ)

+8.81Mn

accumulated since last quarter

Value of Holdings

$1.34Bn

reported market value

Shares Owned by Institutions

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Shares Purchased/Sold by Institutions

Accumulated Distributed

Latest quarter —

Net over range —

Accumulating quarters —

Ownership Summary

Quarter ending 30 Jun, 2026

Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) appears in 194 institutional 13F filings for the quarter ending June 2026.

They owned 91.9% of outstanding stock in June 2026, up from 87.7% the prior quarter.
They increased total shares held in GLUE by 10.43% quarter over quarter, and investors in Monte Rosa Therapeutics increased 70.18% from a year ago.
Activity in GLUE broke down as 111 buyers, 58 sellers, and 25 unchanged among 194 total holders.
In total, institutional investors held 93.29Mn shares in Monte Rosa Therapeutics as of June 2026, up by 8.81Mn shares quarter on quarter, and up 30.89Mn shares year over year.
PRICE T ROWE ASSOCIATES INC /MD/ leads ownership in GLUE with 8.86Mn shares as of June 30, 2026, equal to 8.73% of outstanding shares.
The biggest buyers of Monte Rosa Therapeutics for the quarter ending June 2026 included PRICE T ROWE ASSOCIATES INC /MD/ (2.14Mn), BlackRock, Inc. (1.21Mn), Jupiter Topco LLC (1.07Mn), Vestal Point Capital, LP (996.54K), Woodline Partners LP (888.39K).
Top sellers of GLUE stock for the quarter ending June 2026 included AMERICAN CENTURY COMPANIES INC (1.19Mn), SILVERARC CAPITAL MANAGEMENT, LLC (893.74K), BRAIDWELL LP (755.01K), MONTANOVA CAPITAL, LLC (677.27K), Alphabet Inc. (311.8K).
Monte Rosa Therapeutics's 10 largest shareholders as of June 2026 include PRICE T ROWE ASSOCIATES INC /MD/ (8.86Mn), NEA Management Company, LLC (7.69Mn), BlackRock, Inc. (6.84Mn), TCG Crossover Management, LLC (4.62Mn), Vestal Point Capital, LP (4.6Mn), BVF INC/IL (4.46Mn), BAKER BROS. ADVISORS LP (4.35Mn), State Street Corp (3.73Mn), MONTANOVA CAPITAL, LLC (3.55Mn), VANGUARD CAPITAL MANAGEMENT LLC (3.41Mn) per Business Quant data.

Form 13F Holdings

194 Institutional Holders

Report period 30 Jun, 2026

Total shares held 93.29Mn

Of outstanding 91.93%

#	Institution	CIK	Shares Held	% of Outstanding	Change (QoQ)	Change (%)	Value (USD)
1	PRICE T ROWE ASSOCIATES INC /MD/	0000080255	8,861,171	8.73%	▲2,140,983	+31.86%	$214.44K
2	NEA Management Company, LLC	0001512848	7,692,298	7.58%	0	0.00%	$186.15Mn
3	BlackRock, Inc.	0002012383	6,843,087	6.74%	▲1,205,403	+21.38%	$165.60Mn
4	TCG Crossover Management, LLC	0001839948	4,622,151	4.55%	0	0.00%	$111.86Mn
5	Vestal Point Capital, LP	0001974915	4,600,000	4.53%	▲996,535	+27.65%	$111.32Mn
6	BVF INC/IL	0001056807	4,460,886	4.40%	0	0.00%	$107.95Mn
7	BAKER BROS. ADVISORS LP	0001263508	4,345,736	4.28%	0	0.00%	$105.17Mn
8	State Street Corp	0000093751	3,731,416	3.68%	▲377,436	+11.25%	$90.30Mn
9	MONTANOVA CAPITAL, LLC	0001569064	3,549,539	3.50%	▼677,270	-16.02%	$85.90Mn
10	VANGUARD CAPITAL MANAGEMENT LLC	0002100119	3,412,927	3.36%	▲312,682	+10.09%	$82.59Mn
11	Versant Venture Management, LLC	0001560009	3,180,780	3.13%	0	0.00%	$76.97Mn
12	BRAIDWELL LP	0001920938	2,451,562	2.42%	▼755,012	-23.55%	$59.33Mn
13	GEODE CAPITAL MANAGEMENT, LLC	0001214717	1,864,113	1.84%	▲323,301	+20.98%	$45.12Mn
14	AMERICAN CENTURY COMPANIES INC	0000748054	1,622,846	1.60%	▼1,186,801	-42.24%	$39.27Mn
15	MARSHALL WACE, LLP	0001318757	1,593,600	1.57%	▲160,448	+11.20%	$38.57Mn
16	Aisling Capital Management LP	0001766721	1,555,664	1.53%	0	0.00%	$37.65Mn
17	Bellevue Group AG	0001674546	1,190,000	1.17%	▼60,000	-4.80%	$28.80Mn
18	DIMENSIONAL FUND ADVISORS LP	0000354204	1,177,488	1.16%	▲136,116	+13.07%	$28.49Mn
19	MPM BioImpact LLC	0001687078	1,161,081	1.14%	▼15,847	-1.35%	$28.10Mn
20	SILVERARC CAPITAL MANAGEMENT, LLC	0001816307	1,108,295	1.09%	▼893,745	-44.64%	$26.82Mn

Showing 1 to 20 of 194 holders